Director, Clinical Pharmacokinetics/Pharmacometrics
Roivant Sciences, Inc. is looking for a Director level clinical pharmacokineticist/pharmacometrician that would have clinical pharmacology responsibilities across a broad and growing therapeutic portfolio.
Apply at http://www.roivant.com/ or directly at https://boards.greenhouse.io/roivantsciences/jobs/871622?gh_jid1622#.WdzMQGiPKUk
Details below:
LOCATION: Durham, NC or New York City, NY
THE COMPANY
Roivant Sciences is a development-stage biopharmaceutical company focused on realizing the full value of promising drug candidates and systematically reducing the time, cost and risk of delivering new drugs to market. Roivant aims to develop under-resourced or deprioritized drug candidates across therapeutic areas of significant medical need.
Roivant is rapidly expanding its pipeline and the number of subsidiaries (or "Business Units") around therapeutic areas of interest. There are currently six "Vant" subsidiaries in areas that include dermatology, dementia, rare disease, and women's health (www.roivant.com).
THE ROLE
Roivant's employees are its most important assets. We believe strongly in the importance of building balanced teams, combining those with experience in the biopharmaceutical industry with "natural athletes" who come from other industries - such as finance, consulting and technology - in order to challenge the status quo and shape the future of both our business and the pharmaceutical industry.
We are seeking exceptional talent for the role of Director, Clinical Pharmacokinetics. The individual will provide a strategic role in the Clinical Pharmacology department assessing and determining pharmacokinetic (PK) programs and analysis techniques for use in clinical and nonclinical studies. He/she will also have a significant role in developing new capabilities for the Clinical Pharmacology department within Roivant. This individual will be responsible for clinical pharmacology and PK support across therapeutic areas and all phases of clinical development, including development and execution of clinical pharmacology plans. The employee will be an integral member of the project team using exploratory data analyses techniques, modeling, and simulation to accelerate development and support dosing, study designs, and development plans. The employee will perform PK analyses or provide scientific oversight of PK analyses performed at CROs. There will be significant writing and review of regulatory documents, protocols, and study reports. The employee will also assist in due diligence efforts for potential acquisition of new products and/or technologies.
We are looking for a top quality individual with the following characteristics:
* Deeply motivated self-starter with an entrepreneurial spirit
* Desire to work in a quickly changing, fast-paced environment
* Unrelenting dedication to delivering results and a desire to shape the strategic goals of the business
* Ability to overcome ambiguity and challenge the status quo
* Willing to roll up your sleeves to get the job done
Requirements for consideration include:
* MD, PharmD, or PhD degree
* Minimum 5 years experience in the pharmaceutical industry conducting and managing pharmacokinetic and pharmacodynamic analyses
* Experience includes a clinical pharmacology leadership role on a drug development project team
* Proven track record of clinical pharmacology/pharmacokinetics support for regulatory interactions
* Experience and expertise with Population PK/PD Modeling and/or PBPK modeling is preferred
If you are interested in this role or in other opportunities at Roivant Sciences, please apply at http://www.roivant.com/
Brendan M. Johnson, Ph.D.
Senior Director, Pharmacokinetics
Roivant Sciences, Inc.
324 Blackwell St, Suite 1220,
Durham, NC 27701
brendan.johnson_at_roivant.com<mailto:brendan.johnson_at_roivant.com>
office: +1 (919) 425-5710
mobile:+1 (919) 572-9559
[cid:image001.png_at_01D275BD.54B5B930]
http://www.roivant.com/
This e-mail message (including all attachments) is for the sole use of the intended recipient(s) and may contain confidential and privileged information. If you are not the intended recipient, you must not review, use, disclose, copy, distribute or keep this email, its attachments or the message(s) or information contained in it or attached to it. If you are not the intended recipient, please contact the sender as soon as possible by reply e-mail and thereafter immediately delete this email and destroy all copies of the original message and any attachments. We have taken precautions to minimize the risk of transmitting software viruses, but we advise you to carry out your own virus checks on any attachment to this message. We cannot accept liability for any loss or damage caused by software viruses.
(image/png attachment: image001.png)